Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures.

To see complete record on, please visit this link

Id: NCT04897750

Organisation Name: Cessatech A/S

Overal Status: Recruiting

Start Date: August 19, 2021

Last Update: April 27, 2022

Lead Sponsor: Cessatech A/S

Brief Summary: This is a prospective non-randomized, open-label, single dose (and a second dose if needed), PK study in 25 children age 1-17 years. The proposed number of study participants by subset is: 8 paediatric participants 1-2 years; 8 paediatric participants >2-6 years and 9 paediatric participants >6-17 years.

  • Analgesia

Total execution time in seconds: 0.29273295402527